Local News

Southeast BIO Picks 31 Companies To Present At Investor Forum

Posted Updated

ATLANTA, GA. — Thirty-one life science companies from across the Southeast will make presentations to potential investors at the

Southeast BIO Investor Forum

.

The three-day conference, which is entering its eighth year, is set for Nov. 8-10 at the InterContinental Buckhead Hotel in Atlanta.

"This is an outstanding group of selected companies that will be of interest to the many potential investors already registered for our conference," said Stephen Snowdy, co-chairman of the selection committee. He is an investor with MB Venture Partners of Memphis, TN.

SEBIO represents the life sciences industry across the Carolinas, Georgia, Virginia, Tennessee, Alabama and Florida.

Companies will make 10-minute presentations.

Selected later-stage companies are:

Adlyfe Inc. (Rockville, MD)

AGTC (Alachua, FL)

Aldagen, Inc. (Durham, NC)

Altor Bioscience Corporation (Miramar, FL)

Argos Therapeutics, Inc. (Durham, NC)

Biolex Therapeutics (Pittsboro, NC)

DARA BioSciences, Inc. (Raleigh, NC)

DiaKine Therapeutics (Charlottesville, VA)

Nanotherapeutics, Inc. (Alachua, FL)

NeoVista, Inc. (Atlanta, GA)

NephroGenex (Cary, NC)

Phase Bioscience, Inc. (Durham, NC)

Regado Biosciences (Durham, NC)

RFS Pharma, LLC (Tucker, GA)

Serenex, Inc. (Durham, NC)

Selected Early-Stage Companies are:

3Ti (Atlanta, GA)

Abeome Corporation (Athens, GA)

Addrenex Pharmaceuticals (Morrisville, NC)

AerovectRx Corporation (Atlanta, GA)

AudioFusion Inc. (Winston-Salem, NC)

BioDtech, Inc. (Nashville, TN)

Celtaxsys, Inc. (Atlanta, GA)

Corneal Science Corporation (Raleigh, NC)

InterveXion Therapeutics, LLC (Little Rock, AR)

IntraTherm LLC (Little Rock, AR)

MedShape Solutions (Atlanta, GA)

NanoVici, Inc. (Atlanta, GA)

OcuCure Therapeutics (Roanoke, VA)

Precision BioSciences, Inc. (Durham, NC)

Precision Human BioLaboratories, Inc. (Cary, NC)

ViewRay, Inc. (Gainesville, FL)

Copyright 2024 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.